Table of Contents
PharmSights
| mTOR Signaling and Entrainment of the Mammalian Circadian Clock |
Abstract PDF |
| Ruifeng Cao, Karl Obrietan |
125-130 |
| Intracellular Distribution-based Anticancer Drug Targeting: Exploiting a Lysosomal Acidification Defect Associated with Cancer Cells |
Abstract PDF |
| Rosemary A. Ndolo, Damon T. Jacobs, M. Laird Forrest, Jeffrey P. Krise |
131-136 |
| Vascular Endothelial Growth Factor Regulates Excitatory Synaptic Transmission in Hippocampal Neurons |
Abstract PDF |
| Yu-Fei Huang, Chih-Hao Yang, Chiuan-Shiou Chiou, Chiung-Chun Huang, Kuei-Sen Hsu |
137-141 |
Research Articles
| Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase |
Abstract PDF |
| Stacey L. House, Brian E. House, Betty Glascock, Thomas Kimball, Eyad Nusayr, Jo El J. Schultz, Thomas Doetschman |
143-154 |
| Glyceollins, a Novel Class of Antiestrogenic Phytoalexins |
Abstract PDF |
| Syreeta L. Tilghman, Stephen M. Boué, Matthew E. Burow |
155-160 |
| Soluble Neuregulin and Schwann Cell Myelination: a Therapeutic Potential for Improving Remyelination of Adult Axons |
Abstract PDF |
| Neeraja Syed, Haesun A. Kim |
161-167 |
FDA Corner
| FDA Approves First Oral Drug to Reduce MS Relapses |
Abstract PDF |
| |
169 |
| FDA Approves New Drug for Gout |
Abstract PDF |
| |
169-170 |
| FDA Approves Drug for Chronic Drooling in Children |
Abstract PDF |
| |
170 |
| FDA Approves New Treatment for Prostate Cancer |
Abstract PDF |
| |
170-171 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
